tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (SE:XVIVO)
:XVIVO
Sweden Market

Xvivo Perfusion AB (XVIVO) Financial Statements

Compare
2 Followers

Xvivo Perfusion AB Financial Overview

Xvivo Perfusion AB's market cap is currently kr7.09B. The company's EPS TTM is kr1.045; its P/E ratio is 281.92; Xvivo Perfusion AB is scheduled to report earnings on January 27, 2026, and the estimated EPS forecast is kr0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 812.16Mkr 822.41Mkr 597.54Mkr 415.29Mkr 258.39M
Gross Profitkr 533.50Mkr 616.41Mkr 445.11Mkr 296.96Mkr 188.28M
Operating Incomekr 93.02Mkr 88.35Mkr 4.19Mkr 23.18Mkr 6.98M
EBITDAkr 153.14Mkr 272.97Mkr 35.05Mkr 39.21Mkr 39.20M
Net Incomekr 25.16Mkr 172.18Mkr 91.82Mkr 18.43Mkr 8.15M
Balance Sheet
Cash & Short-Term Investmentskr 292.09Mkr 415.52Mkr 546.09Mkr 246.54Mkr 398.70M
Total Assetskr 2.37Bkr 2.40Bkr 2.20Bkr 1.73Bkr 1.54B
Total Debtkr 237.89Mkr 34.04Mkr 31.44Mkr 10.01Mkr 5.72M
Net Debtkr -54.20Mkr -381.48Mkr -514.35Mkr -236.54Mkr -392.98M
Total Liabilitieskr 260.65Mkr 245.97Mkr 250.57Mkr 302.95Mkr 257.15M
Stockholders' Equitykr 2.11Bkr 2.16Bkr 1.95Bkr 1.43Bkr 1.29B
Cash Flow
Free Cash Flowkr 0.00kr -81.86Mkr -97.65Mkr -103.09Mkr -106.13M
Operating Cash Flowkr 101.07Mkr 111.29Mkr 46.29Mkr 27.86Mkr -12.06M
Investing Cash Flowkr -258.41Mkr -243.81Mkr -161.62Mkr -197.62Mkr -187.70M
Financing Cash Flowkr 72.25Mkr -10.90Mkr 418.55Mkr -6.84Mkr 234.61M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Xvivo Perfusion AB Debt to Assets

Xvivo Perfusion AB Cash Flow

Xvivo Perfusion AB Forecast EPS vs Actual EPS